1. Intracellular recordings were obtained from neurones in layers 2 and 3 of the rat frontal neocortex in an in vitro slice preparation. Three distinct types of stimulation-evoked post-synaptic potentials were recorded in these neurones: excitatory post-synaptic potentials (e.p.s.p.s); bicuculline-sensitive, chloride-dependent inhibitory post-synaptic potentials (i.p.s.p.s) with times to peak of 20-25 ms (fast(f)-i.p.s.p.s); bicuculline-insensitive, potassium-dependent i.p.s.p.s with times to peak of 150-250 ms (long(l)-i.p.s.p.s).
INTRODUCTION
In 1973, Pierau & Zimmermann reported that the GABA analogue baclofen (/3-chlorophenyl-GABA) depressed e.p.s.p.s evoked in cat motoneurones at doses that had no effect on i.p.s.p.s or on the passive electrical properties or direct excitability of these cells. They concluded that baclofen acted presynaptically to inhibit central excitatory neurotransmission, and subsequent electrophysiological studies supported this conclusion (Davidoff & Sears, 1974; Fox, Krnjevic, Morris, Puil & Werman, 1978; Lanthorn & Cotman, 1981; Ault & Nadler, 1982; Olpe, Baudry, Fagni & Lynch, 1982) . There have also been reports, however, that baclofen depresses i.p.s.p.s (Fox et al. 1978; Misgeld, Klee & Z4eise, 1982; Scholfield, 1983) and has a direct hyperpolarizing action on some mammalian central neurones (Misgeld et al. 1982; Newberry & Nicoll, 1984; Brady & Swann, 1984) . This hyperpolarizing action has been shown to be secondary to an increase in a voltage-dependent potassium conductance (Gaihwiler & Brown, 1985; Inoue, Matsuo & Ogata, 1985a; Newberry & Nicoll, 1985) .
It is now established that there are two classes of GABA receptor, GABAA and GABAB, and that baclofen is a protypical agonist at GABAB receptors (Bowery, Hill, Hudson, Doble, Middlemiss, Shaw & Turnball, 1980; Hill & Bowery, 1981) . Because ofthe high density ofGABAB receptor binding sites in the mammalian cerebral cortex (Karbon, Duman & Enna, 1983; Gehlert, Yamamura & Wamsley, 1985) and the multiple actions of baclofen observed in previous electrophysiological studies, we undertook to determine the effects of baclofen on rat neocortical neurones in an in vitro slice preparation. Some of the results were published previously in abstract form (Howe, Sutor & Zieglgiinsberger, 1985; Sutor, Howe & Zieglgainsberger, 1985) .
METHODS
Adult Sprague-Dawley rats (120-160 g) were anaesthetized with ether and decapitated. Their brains were removed rapidly, placed in oxygenated superfusion medium (4 0), and sectioned with a razor blade such that transverse slices ofeach cerebral hemisphere could be cut in a plane of section 540 BACLOFEN ON RAT NEOCORTICAL NEURONES perpendicular to the dorsal surface of the frontal cerebral cortex. Eight serial slices (nominally 500 ,um thick) were cut from the frontal poles of each hemisphere with a Mcllwain Tissue Chopper. After incubation at ambient room temperature for at least 1 h, slices (commonly those from the centre of each set) were placed in a continuous superfusion chamber and the temperature of the superfusion medium in this chamber was slowly heated to and maintained at 36-37 'C. The slices lay on a net and were superfused from below. Warm humidified air was circulated over the chamber to prevent the upper surfaces of the slices from drying.
The standard superfusion medium had the following composition (in mM): NaCl, 122-75; KCl, 5-00; NaH2PO4, 1-25; CaCl2, 2-50; MgSO4, 1P30; NaHCO3, 26; glucose, 10. The superfusion medium was gassed continuously with 95 % 02-5 % CO2 and had a final pH of 7-4. When the concentration of KCI in the standard medium was reduced, this was compensated for with equimolar NaCl. The medium in which TEA was applied contained (in mM): NaCl, 1 1765; KCl, 2-50; CaCl2, 2-50; MgCl, 1P30; NaHCO3; 26; glucose, 10; TEA Cl, 10.
Solutions for superfusion were changed by switching a 4-way valve. The volume of the inflow system from this valve to the chamber was 0-8 ml and the chamber volume was 10 ml. Solutions were superfused at rates of 3 5-5 ml/min. The minimum time for replacement of the chamber volume with a new solution was therefore 20-30 s. With this superfusion system, responses to changes in the ionic composition of the medium required 5-10 min to reach steady state. All solutions were pre-warmed and equilibrated with 95 % 02-5 % CO2.
Intracellular recordings were obtained from neurones in cortical layers 2 or 3 of the dorsomedial region of the slices with glass micro-electrodes that were filled with either potassium acetate (4 M, pH adjusted to 7 0 with acetic acid), potassium methylsulphate (KMeSO4, 2 M), or 1 M-CsCl. Electrodes typically had resistances of 50-80 MCI. Post-synaptic potentials were evoked by electrical stimulation (0 05 ms in duration) of superficial cortical layers with a bipolar silver stimulation electrode that was insulated to within 250 #m of the electrode tips (tip diameter: 100 /sm; separation of tips: 250 psm). The stimulation electrode was positioned such that a line drawn between the tips would be approximately perpendicular to the dorsal surface of the cortex and so that the most dorsal tip of the bipolar electrode was 100-150 ,um from this surface. The stimulation electrode was placed 0-8-15 mm from the medial border of the slice and the tips were advanced into the slice 200-250 ,um . All recordings were obtained medial to and 04-10 mm away from the stimulation electrode. Conventional display techniques were used and signals were stored on magnetic tape (frequency response of tape recorder: 1P25 kHz). In some cases, the replayed signals were digitized and analysed with an LSI 11/73 computer. Intracellular recordings and current injections were performed with a Dagan 8100 amplifier that was equipped with a bridge circuit and also with sample and hold single-electrode current-clamp and voltage-clamp modes (Wilson & Goldner, 1975;  switching frequency set between 1 and 2 kHz, 25 % duty cycle). Some voltage-clamp recordings were made with a npi SECIL (Fa. Polder, F.R.G.) single-electrode voltage-clamp amplifier (switching frequency, 10-12 kHz; duty cycle, 25%). Determinations of RN, neuronal input resistance, were made with 150 ms rectangular-current injections that produced hyperpolarizing voltage transients of < 10 mV or from the slope of current-voltage relation plots. When recordings were made in voltage clamp, neuronal input conductance, 9N, was estimated from the steady-state current responses to 150 ms, 10 mV hyperpolarizing voltage command steps. Membrane potential values were corrected for offset potentials that were determined by rapidly withdrawing the electrode at the end of the recording.
Baclofen was applied at known concentration in the superfusion medium or from micropipettes by ionophoresis or pressure ejection with a Neuro Phore BH2 unit. Unless it is stated otherwise, the racemic mixture was applied. Bicuculline methiodide was applied in the superfusion medium. L-glutamate, L-aspartate, N-methyl-D-aspartate (NMDA), and GABA were applied from micropipettes by ionophoresis. The 4-barrelled micropipettes (total tip broken to 3-5 ,um) for ionophoresis or pressure ejection were positioned under microscopic control as close to the recording electrode as possible with an independent micromanipulator, advanced into the slice, and positioned to obtain maximal responses to ionophoretic ejections of L-glutamate and GABA. Solutions for ionophoresis were: NaCl, 1 M; baclofen, 10 mm, pH 40; GABA, 0-5 M; pH 4-5; sodium L-glutamate or sodium L-aspartate, 1 M, pH 8-0; NMDA, 25 mM; pH 8-0. Baclofen and GABA were ejected with cationic currents and L-glutamate, L-aspartate, and NMDA were ejected with anionic currents. Retaining currents (5-10 nA) were applied when the substances were not ejected actively.
Automatic current neutralization was employed at all times.
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In most cases, the range and mean+ S.D. of the measured values are reported. In cases where the sample size is small or the sample values were not normally distributed, the median value is reported. Two-tailed Student's t tests were used for comparisons of two sample means. Quoted n values refer to the number of neurones for which the result was demonstrated. The reversibility of baclofen's effects is stated as full or partial, respectively, when the measured parameter recovered to within 75-100 % or 50-75% of its value before baclofen.
RESULTS

Characteristics of rat neocortical neurones
Stable intracellular recordings of 1-6 h in duration were obtained from seventy-one neurones upon which baclofen was applied by ionophoresis (n = 15) or pressure ejection (n = 4) from micropipettes or by addition to the superfusion medium (n = 52). Some of the characteristics of these neurones and of their responses to current injections or to electrical stimulation of superficial cortical layers are summarized in (Sutor & Zieglgiinsberger, 1984 Connors, Gutnick & Prince, 1982 Howe, Sutor & Zieglgiinsberger, 1986) .
In some neurones, stimulation of superficial cortical layers also evoked e.p.s.p.s with times to peak of 25-80 ms. These late e.p.s.p.s were always evoked at higher stimulation intensities than the commonly evoked e.p.s.p.s with times to peak of 7-10 ms, but disappeared as the stimulation intensity was increased further and i. Effects of baclofen on synaptic excitability DL-or L-baclofen increased the stimulation threshold for orthodromically evoked action potentials in thirty-nine of forty-four neurones tested (6-233 %, median increase: 27 %). Full or partial reversibility of these effects was demonstrated for twenty-six and two neurones, respectively. Thus, the predominant effect of baclofen was to reduce synaptic excitability (Figs. 4 C and 5B). At suprathreshold stimulation intensities, however, there was often an increase in synaptic excitability, as evidenced by an increase in the number of synaptically evoked action potentials (Fig. 5A) was demonstrated for thirty-five neurones. Depolarizations in response to baclofen were never observed when baclofen was applied at resting Em. In each of seven neurones on which ionophoretic applications of both GABA and baclofen were made at resting Em, GABA produced depolarizations and baclofen produced hyperpolarizations. The amplitude of baclofen-induced hyperpolarizations was increased when Em was depolarized, and in four neurones it was possible to hyperpolarize Em far enough to reverse these hyperpolarizations. Determinations of the reversal potential (EBAC) of Em changes produced by ionophoretically applied baclofen were between -89 and -92 mV in 5 mM-potassium medium (Fig. 6) . Estimations of EBAC were also made from the intersection point of current-voltage relation plots determined in normal and in baclofen-containing media for another fifteen neurones (Ginsborg, 1967) . Mean EBAC values so estimated were -85 + 6 mV and -97 +5 mV in 5 00 and 2-50 mMpotassium media, respectively (n = 8 and 7; values significantly different from each other, P < 0 005). The amplitude of baclofen-induced hyperpolarizations was increased when the potassium concentration of the medium was reduced from 5 00 to 1-25 mm and the EBAC values estimated from the intersection point of currentvoltage relations plots were shifted by -21 and -24 mV.
For twenty-nine of the forty neurones hyperpolarized by baclofen, reductions in RN were measured during these hyperpolarizations (10-58 %, 26+10 %). These RN decreases were not solely the consequence of the anomalous rectification inherent to the neurones, because significant decreases in RN remained when constant current was injected to shift Em back to its pre-application value. Furthermore, in only a few cases were the hyperpolarizations large enough for the inward rectifying behaviour of the cells to influence significantly the magnitude of the RN decreases measured. The most exceptional case was the 58 % reduction in RN measured in a neurone that baclofen hyperpolarized from -69 to -81 mV. In seven neurones, RN decreases were not detected during the small hyperpolarizations produced by baclofen, and reversible decreases in RN (15-30 %) were measured in six neurones that were not hyperpolarized by baclofen.
Current-voltage relation determinations in normal and in baclofen-containing media were made for fifteen neurones. In four cases, comparisons of the resultant 10-30 point plots suggested that the absolute decrease in RN produced by baclofen was greatest at hyperpolarized Em values. In the other eleven cases however, these comparisons gave no indication that baclofen-induced RN changes were voltage dependent. Determinations of the dependence of RN on Em were made (as described in the first section of the Results) in both normal and in baclofen-containing media for eight neurones. These measurements also did not indicate that there was any significant or consistent voltage dependence of the RN decreases measured during baclofen.
Importantly, in virtually every neurone tested, the hyperpolarizations and decreases in RN produced by baclofen recovered before the baclofen-induced depressions of post-synaptic potentials (Fig. 8) . The effects of baclofen on synaptically evoked potentials often outlasted its effects on Em and RN by several minutes.
Effects of baclofen on neurones recorded in voltage clamp
Outward currents in response to ionophoretically applied baclofen or to short bath applications of high concentrations of baclofen were recorded in somatic voltage clamp at holding potentials of -55 to -65 mV in three of four neurones tested (Fig. 7) . These outward currents were associated with 10-20 % increases in 9N. The currents had kinetics similar to the baclofen-induced hyperpolarizations recorded in current clamp from the same neurones and were of sufficient magnitude to account for the magnitude of these hyperpolarizations. Applications of baclofen did not produce measurable currents in either of two cells clamped at a holding potential of -80 mV in 5 mM-potassium medium (Fig. 10) .
Efects of baclofen on direct excitability DL-or L-baclofen increased the magnitude of the depolarizing current necessary to evoke an action potential for twenty-three of twenty-seven neurones tested (11-50 %, 30 + 13 %). Full reversibility of these reductions in direct excitability was demonstrated for seventeen neurones. Baclofen did not change the threshold voltage for action potential generation and had no noticeable effects on action potential rise time or duration. Increases ofdirect excitability during baclofen were never observed. Fig. 9 ). Applications of baclofen that markedly reduced e.p.s.p.s recorded in current clamp, produced no change in the amplitude of L-glutamate-induced inward currents recorded from these same neurones in somatic voltage clamp (n = 2, Fig. 7B ).
Baclofen applications that completely and reversibly blocked f-i.p.s.p.s evoked with suprathreshold stimulation intensities had no effect on depolarizations produced in the same neurones by ionophoretic applications of GABA (n = 3). The decreases Fig. 7 .
in RN associated with these depolarizations were also unaffected by baclofen. Importantly, baclofen (three applications on two neurones) had no effect on inward currents produced by GABA during voltage-clamp recordings (Fig. 10 ).
Reproducibility and concentration dependence of baclofen effects
The reproducibility of baclofen's effects on post-synaptic potentials and on Em and RN were most easily demonstrated when baclofen was applied by ionophoresis, as the effects were then relatively short-lived. The prolonged depressions of post-synaptic potentials produced by bath applications of baclofen limited the possibilities for repeated testing; however, more than one such application was made on eighteen neurones and the results from these neurones also demonstrated convincingly the reproducibility of baclofen's effects and provided no evidence for significant desensitization.
In order to increase the possibility of demonstrating full recovery, high concentrations of baclofen were applied for short times in some experiments. In our experience, however, steady-state responses to changes in the ionic composition of the medium or to bath-applied baclofen are only reached after application times of 5-10 min with our superfusion system. Therefore only applications of baclofen- applications of several concentrations on the same neurone support these conclusions drawn from the pooled data (Fig. 11 B) . Measurable hyperpolarizations and RN decreases were obtained with baclofen concentrations of 100-300 nm. There were no significant differences between the mean amplitudes of baclofen-induced hyperpolarizations and RN decreases that were obtained with baclofen concentrations between 1 and 25 /tM; however, effects of baclofen on Em and RN were observed more consistently as the baclofen concentration was increased over this range.
In our hands, the increase in the magnitude of the depolarizing current required to produce an action potential was the most sensitive and reliable indicator of baclofen's effects on Em and RN. Fig. 11 A also presents a concentration-response curve for baclofen's depressions of direct excitability based on the mean data obtained from twenty-three applications on twelve neurones. The results indicate that the EC50 for baclofen's reductions of direct excitability is approximately 1 /tM. baclofen at 10-30-fold higher concentrations produced no significant effects on any of these parameters (Figs. 12, 13 and 14) . On each of the five neurones tested, 10 min applications of 100 /SM-D-baclofen did not produce any significant effects on Em, RN, or direct excitability, and synaptically evoked potentials were either unaltered or were onl.y slightly reduced (< 20 %). Because the EC50 for each action of DL-baclofen is approximately 1 ,UM, these results indicate that L-baclofen is more than 100-fold J. R. HOWE, B. SUTOR AND W. ZIEGLGANSBERGER GABA or baclofen were applied by ionophoresis at the indicated ejection currents for 10 s (bars below records). Baclofen applications were made approximately 1 min after the corresponding GABA application while: superfusing with normal medium (control, Ba), 20 min after switching to a medium that contained 100 /uM-bicuculline (Bb) and 40 min after returning to normal medium (Bc). GABA (control) depolarizes Em and produces a marked decrease in RN. Both the depolarization and the RN decreases are almost completely and reversibly blocked by bicuculline. At the same Em, baclofen produces a hyperpolarization and a small decrease in RN that are not altered during bicuculline. Potassium acetate recording electrodes, 2-50 mM-potassium media. more potent than D-baclofen at producing each of the effects observed. The potency of DL-and L-baclofen were not compared directly on the same neurones; however, they appeared to be approximately equipotent.
Effects of bicuculline on the actions of baclofen Applications of the GABAA receptor antagonist bicuculline that completely blocked f-i.p.s.p.s and responses to ionophoretically applied GABA had no effect on baclofen's depressions of e.p.s.p.s (Fig. 15A) or on baclofen-induced hyperpolarizations and reductions of RN (Fig. 15B) . Bicuculline was applied at concentrations of 10-100 gm. Applications of 1 /LM-bicuculline are sufficient to markedly reduce f-i.p.s.p.s or the responses of rat neocortical neurones to ionophoretically applied GABA or the GABAA agonist muscimol.
Although both compounds blocked f-i.p.s.p.s, the effects of baclofen and bicuculline were clearly different. On each neurone tested (n = 7), baclofen decreased synaptic excitability, whereas bicuculline increased it (Fig. 16A) . Baclofen increased the stimulation threshold for the bursts of action potentials that were recorded in the presence of bicuculline (Fig. 16B) .
Effects of baclofen on somatic calcium spikes Intracellular injections of caesium ions or superfusion with medium that contained 10 mM-TEA prolonged the duration of directly evoked action potentials 15-100-fold. The duration of such action potentials is reduced reversibly by manganese or cobalt ions, indicating that the increased duration is due to the inward movement of calcium ions when spike repolarization is inhibited. Applications of high concentrations of baclofen (50-200 /zM) did not alter the duration of action potentials recorded in the presence of caesium or TEA in any of the neurones tested (n = 4, Fig. 17 ).
DISCUSSION
Effects of baclofen on stimulation-evoked post-synaptic potentials
The depression by baclofen of e.p.s.p.s is consistent with reports from investigations in other regions of the mammalian C.N.S. (Pierau & Zimmermann, 1973; Fox et al. 1978; Blaxter & Carlen, 1985; Haas, Greene & Olpe, 1985; Inoue, Matsuo & Ogata, 1985 b) . As mentioned, the f-i.p.s.p.s we record in rat neocortical neurones are mediated by GABAA receptors (Sutor & Zieglgainsberger, 1984) . Baclofen also reduces GABAA-receptor-mediated i.p.s.p.s evoked in neurones in the hippocampus and in the olfactory cortex (Misgeld et al. 1982; Scholfield, 1983; Blaxter & Carlen, 1985; Inoue et al. 1985b (Blaxter & Carlen, 1985; Inoue et al. 1985 b) .
The principal effect of baclofen on rat neocortical neurones was to reduce synaptic excitability, although baclofen reduced both f-i.p.s.p.s and l-i.p.s.p.s. Baclofen also increased action potential stimulation thresholds in previous intracellular studies (Pierau & Zimmermann, 1973; Fox et al. 1978; Haas et al. 1985) . although some investigators report that baclofen both increased and decreased action potential thresholds, depending on the cell population investigated and the concentration of baclofen applied (Misgeld et al. 1982; Inoue et al. 1985b) .
The consistency of the increases in action potential stimulation threshold that we observed is in part explained by the characteristic sequence in which post-synaptic potentials are recruited in rat neocortical neurones with the stimulation we employed. Post-synaptic potential sequences evoked with subthreshold stimulation intensities are dominated by e.p.s.p.s, and baclofen's action to depress e.p.s.p.s is therefore of more consequence for these potential sequences than is its action to depress i.p.s.p.s. In addition, baclofen decreased the direct excitability of most neurones tested and this effect also contributes to the action of baclofen to increase the stimulation threshold of the synaptically evoked action potential.
Effects of baclofen on Em and RN
The mean reversal potential of baclofen-induced changes in Em and the dependence of apparent EBAC on the extracellular potassium concentration suggest these changes are secondary to an increase in the conductance of the post-synaptic membrane to potassium ions. Studies of the hyperpolarizing action of baclofen on hippocampal neurones (Newberry & Nicoll, 1984 Giihwiler & Brown, 1985; Inoue et al. 1985a ) and on neurones in the dorsolateral septal nucleus (Stevens, Gallagher & Shinnick-Gallagher, 1985) have shown convincingly that baclofen directly increases the potassium conductance of these cells. The magnitude of the hyperpolarizations produced by baclofen in our experiments was typically only 2-6 mV. Larger amplitude hyperpolarizations in response to baclofen have been reported for other C.N.S. neurones (Misgeld et al. 1982; Brady & Swann, 1984; Pinnock, 1984; Haas et at. 1985; Inoue et al. 1985a; Newberry & Nicoll, 1985) . The magnitudes of the decreases in apparent input resistance we observed were, however, very similar to those produced by baclofen in other c.N.s. neurones (Newberry & Nicoll, 1984; Blaxter & Carlen, 1985; Haas et al. 1985; Inoue et at. 1985 a) . The smaller amplitude hyperpolarizations we observed are therefore probably accounted for by the higher resting Em values of the neurones we recorded.
In cultured hippocampal neurones, baclofen-induced currents exhibit inward rectification (Giihwiler & Brown, 1985) . We recorded baclofen-induced outward currents at holding potentials of -55 to -65 mV, but we did not examine their voltage sensitivity. Inoue et al. (1985a) also concluded that baclofen-induced conductance changes exhibit inward rectification from their comparisons of control currentvoltage relations (obtained during current-clamp recordings) to those obtained in the presence of baclofen. Our similar comparisons of current-voltage relations did not, in most cases, suggest that the conductance increases produced by baclofen were voltage dependent; nor did our estimations of RN from single hyperpolarizing current steps applied at several different Em values provide any consistent evidence for such voltage dependence. The baclofen-induced decreases in RN were commonly quite modest, however, and the interpretation of such current-clamp measurements is complicated by the rectifying behaviour of the neurones themselves. As such, we believe that these results do not exclude a voltage dependence of the baclofen-induced conductance increases we observed. In all major respects, the conductance increases produced by baclofen in rat neocortical neurones are similar in character to those produced by baclofen in other central neurones. This action of baclofen results in decreases in direct excitability.
Pharmacology of baclofen actions
Our results indicate that the EC50 value for each action of baclofen observed is approximately 1 UM. This is similar to estimated EC50 values for baclofen actions observed in other electrophysiologic studies (Ault & Nadler, 1982 , 1983 Collins, (Knutsson, Lindblom & Martensson, 1974; Swahn, Beving & Sedvall, 1979) .
Each action of baclofen was more than 100-fold stereoselective. Quantitatively similar estimations have been made for the stereoselectivity of baclofen actions observed in other electrophysiologic studies (Ault & Nadler, 1982 , 1983 Brady & Swann, 1984; Haas et al. 1985; Inoue et al. 1985a; Newberry & Nicoll, 1985) . Given the extent of this stereoselectivity, L-baclofen should be approximately twice as potent as DL-baclofen. The range of L-baclofen concentrations we applied and the number of neurones we tested were too small, however, to allow us to accurately discriminate a difference in potency of this magnitude. The results of further experiments do indicate, however, that as expected L-baclofen is slightly more potent than DL-baclofen on neocortical neurones (Howe & Zieglgiinsberger, 1986) .
In agreement with previous reports, baclofen-induced hyperpolarizations and decreases in RN were insensitive to blockade by concentrations of the GABAA receptor antagonist bicuculline between 10 and 100 /SM (Brady & Swann, 1984; Newberry & Nicoll, 1984 Pinnock, 1984 ; but see Inoue et al. 1985b ). Baclofeninduced outward currents are also not reduced by GABAA receptor blockade (Giihwiler & Brown, 1985) .
It was concluded on the basis of extracellular recordings that baclofen's depressions of excitatory synaptic transmission are not blocked by GABAA receptor antagonists (Ault & Nadler, 1982; Cain & Simmonds, 1982; Collins et al. 1982; Inoue et al. 1985b ).
Our intracellular results which demonstrate that baclofen's depressions of e.p.s.p.s are resistant to antagonism by bicuculline provide directSupport for this.
Although baclofen blocked i.p.s.p.s, the actions of baclofen and bicuculline on rat neocortical neurones were not synergistic, as they were reported to be on hippocampal granule cells (Misgeld et al. 1982) . Thus, bicuculline consistently and significantly decreases the stimulation thresholds of action potentials in rat neocortical neurones, whereas baclofen consistently increased this threshold. In addition, baclofen increased, rather than decreased, the threshold stimulation intensity required to produce action potential bursts evoked in the presence of bicuculline (cf. Ault & Nadler, 1983; Brady & Swann, 1984) . (Newberry & Nicoll, 1985) . These bicuculline-resistant hyperpolar-izations are observed, however, when GABA is applied to the dendritic field of hippocampal neurones. In our experiments, GABA applications were made from ionophoretic electrodes that were placed as close to the recording electrode as possible, and therefore we have presumably applied GABA only near the soma of neocortical neurones.
The relation between hyperpolarizations and conductance increases produced by baclofen and baclofen's depressions of stimulation-evoked post-synaptic potentials The following experimental findings indicate that, although the action of baclofen to increase post-synaptic potassium conductance certainly contributes to baclofen's depression of stimulation-evoked post-synaptic potentials, this action alone cannot account for the depressions of these potentials that were produced by baclofen. First, the effects could be dissociated. For several neurones, post-synaptic potentials were markedly reduced by baclofen, but changes in RN were not detected. Conversely, in a few neurones baclofen produced hyperpolarizations and typical decreases in RN, but the reductions of post-synaptic potentials were considerably less than those commonly observed. Secondly, whereas for the majority of neurones baclofen both decreased post-synaptic potentials and produced hyperpolarizations and detectable decreases in RN, baclofen applications that produced 70- 
